v1-vs-v2

v1 vs v2 executive comparison: which is the stronger Google.org pitch?

Metadata

Statusdone
Assignedagent-31
Agent identity3184716484e6f0ea08bb13539daf07686ee79d440505f1fdf2de0357707034c3
Created2026-05-01T18:40:11.112354551+00:00
Started2026-05-01T18:40:53.789159481+00:00
Completed2026-05-01T18:44:36.838722129+00:00
Tagsgrant,urgent,decision-support, eval-scheduled
Eval score0.92
└ blocking impact1.00
└ completeness0.95
└ constraint fidelity0.85
└ coordination overhead0.95
└ correctness0.90
└ downstream usability0.90
└ efficiency0.85
└ intent fidelity0.82
└ style adherence0.95

Description

Description

The grant proposal is due TODAY. Erik is asking — as a sanity check at the eleventh hour — what v1 was proposing and whether v2 is genuinely stronger. He needs an honest, fast read, not a justification of an already-made decision.

Erik's question, verbatim: 'what do you think is the strongest'

Project convention: notes go to ~/poietic.life/notes/ (Erik's stated routing). Use ~/poietic.life/notes/v1-vs-v2-executive-comparison-20260501.md.

What to do

  1. Read workgraph_google_application_FINAL.md (v1) and workgraph_extended_outline.md (v1).
  2. Read workgraph_google_application_FINAL_v2.md (v2) and workgraph_extended_outline_v2.md (v2).
  3. Read STATE.md §5 (the v2 pivot decision log) — Erik wants to see the case made for the pivot, not just trust it.
  4. Produce a single output file with these sections, each tight:

Section A: v1 in 150 words

What v1 proposed: scientific spine, demonstration design, key claims, deliverables. No spin.

Section B: v2 in 150 words

Same shape. No spin.

Section C: Honest comparison (300 words max)

For each of these dimensions, state which arm is stronger and why. If they're a wash, say so:

  • Translational impact (Google.org cares about real-world benefit; rare disease patients vs cancer patients)
  • Defensibility against expert reviewers (which spine is harder to poke holes in given current literature?)
  • Authenticity to the founders' track record (Erik = vg/PGGB pangenomics; Luca = CRISPResso/CRISPRme; Vaughn = org design)
  • Demonstration credibility (PHR methodology comparison vs drug-discovery competition — which produces something a reviewer can actually evaluate?)
  • Risk of falling apart under scrutiny (overclaim risk, COI risk, data-availability risk)
  • Fit to Google's stated priorities (Functional Genomics vs AlphaFold-style structural pipeline)

Section D: Recommendation (100 words)

Submit v2 / submit v1 / hybrid / something else. State the call plainly. If v2 is the right call, say what v1 had that v2 should claw back before submission. If v1 is the right call, say so and flag that we'd need an emergency reversal.

Constraints

  • Style: no em-dashes (CLAUDE.md style rule).
  • Be honest. Erik incorporated the company, he can take a real assessment. Don't rubber-stamp v2 just because it's the v2 pivot.
  • Cap each section to its word limit. The whole doc should be under 800 words.

Validation

  • All four files actually read (v1 application, v1 outline, v2 application, v2 outline)
  • STATE.md §5 decision log read
  • Six comparison dimensions each get a verdict
  • Recommendation is a single clear call, not 'it depends'
  • Output at ~/poietic.life/notes/v1-vs-v2-executive-comparison-YYYYMMDD.md
  • Doc is under 800 words total

Depends on

Required by

Log